Biomedical Engineering Reference
In-Depth Information
20. Guo, S., F. Huang, and P. Guo, Construction of folate-conjugated pRNA
of bacteriophage phi29 DNA packaging motor for delivery of chimeric
siRNA to nasopharyngeal carcinoma cells.
Gene Ther
, 2006.
13
(10):
pp. 814-820.
21. Alshamsan, A.,
, Formulation and delivery of siRNA by oleic acid
and stearic acid modified polyethylenimine.
et al.
Mol Pharm
, 2009.
6
(1):
pp. 121-133.
22. Zintchenko, A.,
, Simple modifications of branched PEI lead to
highly efficient siRNA carriers with low toxicity.
et al.
Bioconjug Chem
, 2008.
(7): pp. 1448-1455.
23. Howard, K.A.,
19
, Chitosan/siRNA nanoparticle-mediated TNF-
alpha knockdown in peritoneal macrophages for anti-inflammatory
treatment in a murine arthritis model.
et al.
Mol Ther
, 2009.
17
(1):
pp. 162-168.
24. Nawroth, I.,
, Intraperitoneal administration of chitosan/dsiRNA
nanoparticles targeting TNFalpha prevents radiation-induced fibrosis.
Radiother Oncol
et al.
, 2010.
97
(1): pp. 143-148.
25. Howard, K.A.,
et al.
, RNA interference
in vitro
and
in vivo
using a
novel chitosan/siRNA nanoparticle system.
Mol Ther
, 2006.
14
(4):
pp. 476-484.
26. Zhang, W.,
, Inhibition of respiratory syncytial virus infection with
intranasal siRNA nanoparticles targeting the viral NS1 gene.
et al.
Nat Med
,
(1): pp. 56-62.
27. Tiemann, K., and J.J. Rossi, RNAi-based therapeutics-current status,
challenges and prospects.
2005.
11
EMBO Mol Med
, 2009.
1
(3): pp. 142-151.
28. Wu, S.Y.,
, Development of a novel method for formulating stable
siRNA-loaded lipid particles for
et al.
in vivo
use.
Pharm Res
, 2009.
26
(3):
pp. 512-522.
29. Zhang, Y.,
et al.
, Engineering mucosal RNA interference
in vivo
.
Mol
Ther
, 2006.
14
(3): pp. 336-342.
30. Ogris, M.,
, PEGylated DNA/transferrin-PEI complexes: reduced
interaction with blood components, extended circulation in blood
and potential for systemic gene delivery.
et al.
Gene Ther
, 1999.
6
(4):
pp. 595-605.
31. Akinc, A.,
, A combinatorial library of lipid-like materials
for delivery of RNAi therapeutics.
et al.
Nat Biotechnol
, 2008.
26
(5):
pp. 561-569.
32. Judge, A.D.,
, Confirming the RNAi-mediated mechanism of action
of siRNA-based cancer therapeutics in mice.
et al.
J Clin Invest
, 2009.
119
(3):
pp. 661-673.
Search WWH ::
Custom Search